Publishing research using ab32085? Please let us know so that we can cite the reference in this datasheet.

ab32085 has been referenced in 17 publications.

  • Guo C  et al. microRNA-10b expression and its correlation with molecular subtypes of early invasive ductal carcinoma. Exp Ther Med 15:2851-2859 (2018). PubMed: 29599829
  • Xie H & Wang H PRL-3 promotes breast cancer progression by downregulating p14ARF-mediated p53 expression. Oncol Lett 15:2795-2800 (2018). PubMed: 29435006
  • Hong MK  et al. Expression of Estrogen and Progesterone Receptor in Tumor Stroma Predicts Favorable Prognosis of Cervical Squamous Cell Carcinoma. Int J Gynecol Cancer 27:1247-1255 (2017). PubMed: 28472813
  • Xia X  et al. Nearly asymptomatic intracranial capillary hemangiomas: A case report and literature review. Exp Ther Med 14:2007-2014 (2017). PubMed: 28962117
  • Lou Y  et al. Estradiol Suppresses TLR4-triggered Apoptosis of Decidual Stromal Cells and Drives an Anti-inflammatory TH2 Shift by Activating SGK1. Int J Biol Sci 13:434-448 (2017). PubMed: 28529452
  • Yuan J  et al. Ulipristal Acetate Antagonizes the Inhibitory Effect of Progesterone on Ciliary Beat Frequency and Upregulates Steroid Receptor Expression Levels in Human Fallopian Tubes. Reprod Sci 22:1516-23 (2015). PubMed: 26045548
  • Du P  et al. Methyltransferase-like 17 physically and functionally interacts with estrogen receptors. IUBMB Life 67:861-8 (2015). PubMed: 26488768
  • Yin K Positive correlation between expression level of mitochondrial serine hydroxymethyltransferase and breast cancer grade. Onco Targets Ther 8:1069-74 (2015). IHC-P ; Human . PubMed: 25999742
  • Li LL  et al. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI. Breast Cancer Res 16:R56 (2014). PubMed: 24886710
  • Argenta PA  et al. Predicting response to the anti-estrogen fulvestrant in recurrent ovarian cancer. Gynecol Oncol N/A:N/A (2013). ICC/IF ; Human . PubMed: 23911795
  • Ariazi EA  et al. Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time. Proc Natl Acad Sci U S A 108:18879-86 (2011). WB ; Human . PubMed: 22011582
  • Tieszen CR  et al. Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression. BMC Cancer 11:207 (2011). WB . PubMed: 21619605
  • Hennessy BT  et al. A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers. Clin Proteomics 6:129-51 (2010). Dot blot ; Human . PubMed: 21691416
  • Meng CX  et al. Effects of oral and vaginal administration of levonorgestrel emergency contraception on markers of endometrial receptivity. Hum Reprod 25:874-83 (2010). PubMed: 20139427
  • Hennessy BT  et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69:4116-24 (2009). PubMed: 19435916
  • Kim WY  et al. A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy. Cancer Prev Res (Phila) 1:577-87 (2008). PubMed: 19139008
  • Yin P  et al. Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells. J Clin Endocrinol Metab 92:4459-66 (2007). PubMed: 17785366


Sign up